CASI Pharmaceuticals Inc. (CASI)
NASDAQ: CASI
· Real-Time Price · USD
2.35
0.41 (21.13%)
At close: Aug 15, 2025, 3:59 PM
2.00
-14.89%
After-hours: Aug 15, 2025, 07:47 PM EDT
CASI Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -40.48M | -39.26M | -30.94M | -27.18M | -30.46M | -26.94M | -40.22M | -40.61M | -37.87M | -40.26M | -26.31M | -31.31M | -30.56M | -35.84M | -44.47M | -51.21M | -52.96M |
Depreciation & Amortization | n/a | n/a | n/a | n/a | n/a | n/a | 890K | 1.66M | 1.99M | 2.42M | 1.95M | 1.6M | 1.73M | 1.81M | 1.88M | 1.9M | 1.95M |
Stock-Based Compensation | 1.31M | 1.31M | 7.22M | 7.22M | 7.22M | 7.22M | 1.42M | 3.18M | 5.1M | 7.01M | 8.3M | 8.56M | 7.68M | 7.77M | 7.2M | 6.97M | 7.91M |
Other Working Capital | n/a | n/a | n/a | n/a | n/a | n/a | 1.34M | 1.36M | 8K | -315K | 1.69M | 593K | 1.03M | 1M | -2.1M | -1.64M | -951K |
Other Non-Cash Items | 39.17M | 37.95M | 23.73M | 19.97M | 23.24M | 19.72M | 34.37M | 29.28M | 20.53M | 16.39M | 3.15M | 3.94M | 3.85M | 7.83M | 13.77M | 24.63M | 23.55M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -5.87M | -2.65M | -3.63M | -5.2M | -2.07M | -7.27M | -5.07M |
Change in Working Capital | n/a | n/a | n/a | n/a | n/a | n/a | 2.7M | -873K | -6.61M | -6.65M | -9.11M | -5.37M | -2.15M | -3.22M | -3.53M | -5.23M | -4.64M |
Operating Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a | -843K | -7.37M | -16.85M | -21.09M | -27.89M | -25.22M | -23.08M | -26.84M | -27.23M | -30.2M | -29.25M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | -3.43M | -3.89M | -3.32M | -5.61M | -7.4M | -9.76M | -11.31M | -15.5M | -17.57M | -25.6M | -25.81M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | -1.29M | -1.29M | n/a | n/a | 1.29M | 1.3M | 10K | 10K | 10K | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | -4.46M | -4.46M | -7.42M | -7.42M | 2.62M | 2.06M | 4.27M | -1.32M | -6.99M | -6.5M | -5.75M |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | 19.41M | 36.33M | 37.62M | 37.62M | 18.21M | 1.47M | 172K | 172K | 172K | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | 7.73M | 24.65M | 23.5M | 23.5M | 10.65M | -6.35M | -5.94M | -11.53M | -11.62M | -6.01M | -7.26M |
Investing Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a | 17.95M | 34.41M | 33.45M | 31.16M | 8.46M | -10.9M | -10.91M | -20.69M | -28.52M | -31.03M | -33.23M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | -3M | -1M | n/a | n/a | 1.92M | -547K | -1.55M | -839K | 1.03M | 1.49M | 1.96M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | -267K | -267K | -267K | -3.27M | -3M | -3M | -3M | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -2.02M | -2.04M | -4.77M | -4.75M |
Financial Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a | -3.27M | -1.27M | -267K | -3.27M | -1.08M | -3.55M | -4.55M | 29.64M | 31.49M | 72.92M | 73.41M |
Net Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a | 17.87M | 28.25M | 17.85M | 8.41M | -23.88M | -41.49M | -38.86M | -18.36M | -21.47M | 15.47M | 14.23M |
Free Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a | -4.27M | -11.26M | -20.17M | -26.7M | -35.29M | -34.98M | -34.39M | -42.34M | -44.8M | -55.8M | -55.06M |